Cytoprotective Peptides
BPC-157
5mgC₆₂H₉₈N₁₆O₂₂
Key Research Findings
- Sikiric et al., multiple rodent assay reports — VEGF / NO pathway modulation.
- Published animal-model data on gastric mucosa cell-line assays.
- Stability profile documented in lyophilised storage at −20 °C.
Overview
BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in human gastric juice. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro and animal-model studies to interact with the VEGF and growth-hormone receptor pathways and to modulate nitric oxide synthesis. Not intended for human or veterinary use.
Research Effects
VEGF Pathway Activity
Extensive ResearchReported in published in-vitro assays as a modulator of vascular endothelial growth factor receptor expression.
Nitric Oxide Modulation
Moderate ResearchAnimal-model studies report modulation of nitric oxide synthesis pathways under controlled in-vitro conditions.
ERK1/2 Signalling
Moderate ResearchIn-vitro cell-line assays report effects on the ERK1/2 phosphorylation cascade.
Laboratory Research Only — All information on this page is provided for scientific research purposes only. This is a certified reference material sample sold and distributed for laboratory research only.
Quick Facts
Research Status Key
Featured in Bundles
BPC-157 is included in the following Zenterex research peptide bundles.
Related Peptides
Cytoprotective Peptides
TB-500
TB-500 is a synthetic analogue of the thymosin β4 (Tβ4) fragment. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
Copper & Collagen Peptides
GHK-Cu
GHK-Cu is a synthetic copper-tripeptide complex (Glycyl-L-Histidyl-L-Lysine bound to Cu²⁺). Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
Cytoprotective Peptides
KPV
KPV is a synthetic tripeptide fragment of the α-MSH C-terminal sequence. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →